banner add

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

November 26, 2024 0
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

from NYT > Health https://ift.tt/pUmI5sh
via IFTTT
Tags:

No comments

Subscribe to: Post Comments ( Atom )

RFK Jr. Allies Target States to Overturn Vaccine Mandates for Schools

Proponents of vaccines warn that the efforts will further dismantle the immunization infrastructure and lead to more outbreaks of disease. ...

Theme images by PLAINVIEW. Powered by Blogger.